Literature DB >> 10103188

High-frequency, in vitro reversible switching of Candida lusitaniae clinical isolates from amphotericin B susceptibility to resistance.

S A Yoon1, J A Vazquez, P E Steffan, J D Sobel, R A Akins.   

Abstract

Recent studies have revealed an increase in the incidence of serious infections caused by non-albicans Candida species. Candida lusitaniae is of special interest because of its sporadic resistance to amphotericin B (AmB). The present in vitro study demonstrated that, unlike other Candida species, C. lusitaniae isolates frequently generated AmB-resistant lineages form previously susceptible colonies. Cells switching from a resistant colony to a susceptible phenotype were also detected after treatment with either UV light, heat shock, or exposure to whole blood, all of which increased the frequency of switching. In some C. lusitaniae lineages, after a cell switched to a resistant phenotype, the resistant phenotype was stable; in other lineages, colonies were composed primarily of AmB-susceptible cells. Although resistant and susceptible lineages were identical in many aspects, their cellular morphologies were dramatically different. Switching mechanisms that involve exposure to antifungals may have an impact on antifungal therapeutic strategies as well as on standardized susceptibility testing of clinical yeast specimens.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10103188      PMCID: PMC89214     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  72 in total

1.  Effects of low concentrations of zinc on the growth and dimorphism of Candida albicans: evidence for zinc-resistant and -sensitive pathways for mycelium formation.

Authors:  G W Bedell; D R Soll
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

2.  Fatal septicemia due to amphotericin B-resistant Candida lusitaniae.

Authors:  R Guinet; J Chanas; A Goullier; G Bonnefoy; P Ambroise-Thomas
Journal:  J Clin Microbiol       Date:  1983-08       Impact factor: 5.948

Review 3.  Clinical pharmacokinetics of systemic antifungal drugs.

Authors:  T K Daneshmend; D W Warnock
Journal:  Clin Pharmacokinet       Date:  1983 Jan-Feb       Impact factor: 6.447

4.  Rates of amphotericin B and filipin association with sterols. A study of changes in sterol structure and phospholipid composition of vesicles.

Authors:  S Clejan; R Bittman
Journal:  J Biol Chem       Date:  1985-03-10       Impact factor: 5.157

5.  In vitro susceptibilities of sucrose-negative Candida tropicalis, Candida lusitaniae, and Candida norvegensis to amphotericin B, 5-fluorocytosine, miconazole, and ketoconazole.

Authors:  D G Ahearn; M S McGlohn
Journal:  J Clin Microbiol       Date:  1984-03       Impact factor: 5.948

6.  Application of biotyping and DNA typing of Candida albicans to the epidemiology of recurrent vulvovaginal candidiasis.

Authors:  S Mercure; S Poirier; G Lemay; P Auger; S Montplaisir; L de Repentigny
Journal:  J Infect Dis       Date:  1993-08       Impact factor: 5.226

7.  A comparison of the effects of several antifungal imidazole derivatives and polyenes on Candida albicans: an ultrastructural study by scanning electron microscopy.

Authors:  M Bastide; S Jouvert; J M Bastide
Journal:  Can J Microbiol       Date:  1982-10       Impact factor: 2.419

8.  Effect of ketoconazole on the fungicidal action of amphotericin B in Candida albicans.

Authors:  I J Sud; D S Feingold
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

9.  Comparison of restriction enzyme analysis versus pulsed-field gradient gel electrophoresis as a typing system for Torulopsis glabrata and Candida species other than C. albicans.

Authors:  J A Vazquez; A Beckley; S Donabedian; J D Sobel; M J Zervos
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

10.  Candida lusitaniae: frequency of recovery, colonization, infection, and amphotericin B resistance.

Authors:  W G Merz
Journal:  J Clin Microbiol       Date:  1984-12       Impact factor: 5.948

View more
  16 in total

Review 1.  Epidemiology of invasive candidiasis: a persistent public health problem.

Authors:  M A Pfaller; D J Diekema
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

2.  Alternative identification test relying upon sexual reproductive abilities of Candida lusitaniae strains isolated from hospitalized patients.

Authors:  F François; T Noël; R Pépin; A Brulfert; C Chastin; A Favel; J Villard
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

3.  A STE12 homolog is required for mating but dispensable for filamentation in candida lusitaniae.

Authors:  L Y Young; M C Lorenz; J Heitman
Journal:  Genetics       Date:  2000-05       Impact factor: 4.562

4.  Change in colony morphology of Candida lusitaniae in association with development of amphotericin B resistance.

Authors:  Nancy B McClenny; Haihua Fei; Ellen J Baron; Ana C Gales; Allison Houston; Richard J Hollis; Michael A Pfaller
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

5.  Phenotypic switching in Candida lusitaniae on copper sulfate indicator agar: association with amphotericin B resistance and filamentation.

Authors:  Nancy S Miller; James D Dick; William G Merz
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

6.  Phenotypic switching of Candida guilliermondii is associated with pseudohyphae formation and antifungal resistance.

Authors:  Eglė Lastauskienė; Jolita Čeputytė; Irutė Girkontaitė; Auksė Zinkevičienė
Journal:  Mycopathologia       Date:  2014-12-07       Impact factor: 2.574

7.  Disruption of ergosterol biosynthesis confers resistance to amphotericin B in Candida lusitaniae.

Authors:  Laura Y Young; Christina M Hull; Joseph Heitman
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

8.  In vitro activity of seven systemically active antifungal agents against a large global collection of rare Candida species as determined by CLSI broth microdilution methods.

Authors:  D J Diekema; S A Messer; L B Boyken; R J Hollis; J Kroeger; S Tendolkar; M A Pfaller
Journal:  J Clin Microbiol       Date:  2009-08-26       Impact factor: 5.948

Review 9.  Invasive oesophageal candidiasis: current and developing treatment options.

Authors:  Jose A Vazquez
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 10.  Invasive fungal infection in haematopoietic stem cell transplant recipients: epidemiology from the transplant physician's viewpoint.

Authors:  E J Bow
Journal:  Mycopathologia       Date:  2009-04-03       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.